Midi Health's Series A funding round was led by Google Ventures. In total, Midi Health has raised $40 million, including from Felicis, Semper Virens, Icon, 25M and Operator Collective. The company offers virtual care for those going through perimenopause or menopause.
GV, formerly known as Google Ventures, led a $100 million funding round in Verana Health. The San Francisco-based company aggregates clinical data for medical research and analytics.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Third Rock and ARCH led the launch of the company, which will look at ways to target genetic modifiers that can protect against certain diseases.
The round, led by SoftBank Vision Fund, is more than six times the size of Relay's Series B round, which it closed in December 2017.
Mountain View, California-based DNAnexus has closed a $58 million financing round led by Foresite Capital. Microsoft, TPG Biotech, WuXi NextCODE, GV (formerly Google Ventures), MidCap Financial and Claremont Creek Ventures also participated.
EHRs don't always get the most love from providers. But with its OncoEMR, New York City-based startup Flatiron Health is rethinking the concept of an EHR and everything it encompasses.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Former Google Ventures (GV) CEO Bill Maris is reportedly about to close on a $100 million San Diego-based venture fund, for which he is the sole investor. The catch? This story has played out before.
Bill Maris, who cofounded GV (formerly Google Ventures) and led the firm from 2009 until earlier this year, is rumored to be setting up shop in San Diego with a new $230 million healthcare fund.
Krishna Yeshwant, the part-time physician who leads GV's (formerly Google Ventures) life sciences and health investment team, discusses the kind of consumer wearable company that would win its support.
AstraZeneca joins other notable investors like GV (Google Ventures) and Novartis to fund Rani Therapeutics' oral biologics.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Forty Seven has licensed more than 100 patents from Stanford University that are related to the company's lead therapeutic, monoclonal antibody Hu5F9-G4, as well as a number of novel immune checkpoint inhibitors and cancer-specific antibodies.
Also, we talk about the big health security glitch of the week: Tech issues at Hospital Corporation of America that led to the shutdown of some of its electronic health record system.
Verily, formerly known as Google Life Sciences, is aimed at melding tech and healthcare "to create a true picture of human health."
Here's an overview of how Google Ventures has invested in healthcare and the life sciences just this year.
Understanding primary care to grasp the future of medicine, and other stories that marked the week of healthcare in business.